Cargando…

Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection

BACKGROUND: Plasmacytoid dendritic cells (pDCs) are present in various primary and metastatic human neoplasms; however, their clinical significance in intrahepatic cholangiocarcinoma is not clear. METHODS: To evaluate pDCs’ distributions in and around tumors as well as their potential function and p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Zhi-Qiang, Zhou, Zheng-Jun, Luo, Chu-Bin, Xin, Hao-Yang, Li, Jia, Yu, Song-Yang, Zhou, Shao-Lai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716503/ https://www.ncbi.nlm.nih.gov/pubmed/33292317 http://dx.doi.org/10.1186/s12935-020-01676-z

Ejemplares similares

Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma
por: Cheng, Chi-Tung, et al.
Publicado: (2015)

Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors
por: Liu, Rui-qing, et al.
Publicado: (2013)

High expression of Oct4 and Nanog predict poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection
por: Zhang, Mei-xia, et al.
Publicado: (2019)

Locoregional therapies in patients with recurrent intrahepatic cholangiocarcinoma after curative resection
por: Liu, Hsiao-Tien, et al.
Publicado: (2020)

Risk Factors and Outcomes of Early Relapse After Curative Resection of Intrahepatic Cholangiocarcinoma
por: Yang, Hua, et al.
Publicado: (2019)

An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection
por: He, Chaobin, et al.
Publicado: (2021)

Relationship between PD-L1 expression, CD8+ T-cell infiltration and prognosis in intrahepatic cholangiocarcinoma patients
por: Deng, Min, et al.
Publicado: (2021)

PIWIL4 and SUPT5H combine to predict prognosis and immune landscape in intrahepatic cholangiocarcinoma
por: Zou, Wenbo, et al.
Publicado: (2021)

Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection
por: Zhang, Yong, et al.
Publicado: (2019)

Peritumoral ductular reaction can be a prognostic factor for intrahepatic cholangiocarcinoma
por: Shen, Zhenyang, et al.
Publicado: (2020)

Overexpression of interleukin‐35 in intrahepatic cholangiocarcinoma is a prognostic indicator after curative resection
por: Zhang, Mei‐xia, et al.
Publicado: (2018)

Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection
por: Jing, Chu-Yu, et al.
Publicado: (2016)

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019)

Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2022)

Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence
por: Chan, Kun-Ming, et al.
Publicado: (2018)

Prognostic value of inflammation-based indexes for intrahepatic cholangiocarcinoma following curative resection
por: Wu, Yunhua, et al.
Publicado: (2019)

Specific risk factors contributing to early and late recurrences of intrahepatic cholangiocarcinoma after curative resection
por: Wang, Changzheng, et al.
Publicado: (2019)

Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection
por: Qu, Wei-Feng, et al.
Publicado: (2020)

High level of CD73 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Xu, Ya-ping, et al.
Publicado: (2021)

Investigating effects of preoperative inflammatory biomarkers on predicting survival outcomes of intrahepatic cholangiocarcinoma after curative resection
por: Zhang, Zeyu, et al.
Publicado: (2020)

Development and external validation of a prognosis model to predict outcomes after curative resection of early-stage intrahepatic cholangiocarcinoma
por: Wang, Jianping, et al.
Publicado: (2023)

Failure patterns after curative resection for intrahepatic cholangiocarcinoma: possible implications for postoperative radiotherapy
por: Yu, Wei, et al.
Publicado: (2019)

Recurrence after Curative Resection for Intrahepatic Cholangiocarcinoma: How to Predict the Chance of Repeat Hepatectomy?
por: Langella, Serena, et al.
Publicado: (2021)

Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma
por: Xu, Ying, et al.
Publicado: (2023)

SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Ning, Shanglei, et al.
Publicado: (2018)

ESR1 as a recurrence-related gene in intrahepatic cholangiocarcinoma: a weighted gene coexpression network analysis
por: Li, Fengwei, et al.
Publicado: (2021)

KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinoma
por: Gao, Zheng, et al.
Publicado: (2022)

Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis
por: Labidi-Galy, Sana Intidhar, et al.
Publicado: (2012)

Preoperative neutrophil-to-lymphocyte ratio is prognostic for early recurrence after curative intrahepatic cholangiocarcinoma resection
por: Choi, Woo Jin, et al.
Publicado: (2023)

Diffuse reduction of spleen density is a novel prognostic marker for intrahepatic cholangiocarcinoma after curative resection
por: Deng, Li-Ming, et al.
Publicado: (2021)

Positive Expression of Programmed Death Ligand 1 in Peritumoral Liver Tissue is Associated with Poor Survival after Curative Resection of Hepatocellular Carcinoma()
por: Dai, Xiaomeng, et al.
Publicado: (2017)

Upregulated expression of HOXB7 in intrahepatic cholangiocarcinoma is associated with tumor cell metastasis and poor prognosis
por: Dai, Longfei, et al.
Publicado: (2019)

Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Liu, Lingyun, et al.
Publicado: (2018)

CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis
por: Miyata, Tatsunori, et al.
Publicado: (2019)

Association of BRAF Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic Cholangiocarcinoma
por: Xin, Hao-Yang, et al.
Publicado: (2023)

Prognostic Value of Inflammatory and Tumour Markers in Small-Duct Subtype Intrahepatic Cholangiocarcinoma after Curative-Intent Resection
por: Ma, Bingqi, et al.
Publicado: (2021)

Overexpression of semaphorin 3A promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma after curative resection
por: Hu, Zhi-Qiang, et al.
Publicado: (2016)

Intrahepatic cholangiocarcinoma induced M2-polarized tumor-associated macrophages facilitate tumor growth and invasiveness
por: Yuan, Hui, et al.
Publicado: (2020)

Complex Liver Resections for Intrahepatic Cholangiocarcinoma
por: Reese, Tim, et al.
Publicado: (2021)

High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Huang, Yu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6ohbscm57r1fuagidgokv6tqob